Cd20 Expression and Effects on Outcome of Relapsed/ Refractory Diffuse Large B Cell Lymphoma after Treatment with Rituximab [electronic resource]
Producer: 20180830Description: 331-335 p. digitalISSN:- 2476-762X
- Adult
- Aged
- Aged, 80 and over
- Antigens, CD20 -- metabolism
- Antineoplastic Agents, Immunological -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Drug Resistance, Neoplasm
- Female
- Follow-Up Studies
- Humans
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- diagnosis
- Prognosis
- Remission Induction
- Retrospective Studies
- Rituximab -- therapeutic use
- Survival Rate
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.